1
|
Muñoz-Negro JE, Aguado Bailón L, Calvo Rivera P, Cervilla JA. A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder. Int Clin Psychopharmacol 2021; 36:257-263. [PMID: 34270506 DOI: 10.1097/yic.0000000000000374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Evidence on the effectiveness of psychopharmacological treatment of schizoaffective disorder is scarce and mostly comes from indirect, nonspecific sources. We carried out a large retrospective study (n = 770) of every other consecutively numbered clinical record with a recorded ICD-10 diagnosis of schizoaffective disorder in the Andalusian Health Service record system. We gathered sociodemographic, drug treatment and clinical outcomes such as improvement, relapses and change over time on DSM-5 psychotic dimensions. We analyzed data to explore associations between drug use and clinical improvement. Antipsychotics were the most commonly used drugs (77%). 22.4% of patients experienced at least a mild improvement. Clozapine (odds ratio [OR] = 2.4) and aripiprazole (OR = 2.3) for global improvement, and quetiapine (OR = 3.5) for depression were the most effective drugs. Antidepressants, mood stabilizers and benzodiazepines were also associated with a better outcome in some DSM-5 dimensions such as delusions, hallucinations and language, respectively. Antipsychotic monotherapy was not associated with a better outcome. Our findings corroborate the role of antipsychotics as the essential psychopharmacological treatment for different symptoms of schizoaffective disorder. However, the role of mood stabilizers, antidepressants or BZD is controversial and should be individually considered.
Collapse
Affiliation(s)
- José E Muñoz-Negro
- Mental Health Unit, Clínico San Cecilio University Hospital
- Department of Psychiatry, University of Granada
- Bio-Environmental Psychiatry Research Group E05, Instituto de Investigación Sanitaria IBS, Granada, Spain
| | | | | | - Jorge A Cervilla
- Mental Health Unit, Clínico San Cecilio University Hospital
- Department of Psychiatry, University of Granada
- Bio-Environmental Psychiatry Research Group E05, Instituto de Investigación Sanitaria IBS, Granada, Spain
| |
Collapse
|
2
|
Martínez-Ortega JM, Nogueras P, Muñoz-Negro JE, Gutiérrez-Rojas L, González-Domenech P, Gurpegui M. Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study. J Psychosom Res 2019; 124:109780. [PMID: 31443809 DOI: 10.1016/j.jpsychores.2019.109780] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 07/16/2019] [Accepted: 07/17/2019] [Indexed: 02/08/2023]
Abstract
OBJECTIVE To compare quality of life (QoL), anxiety and depressive symptoms, alcohol consumption and other correlates between patients with psoriasis and controls; and to identify features of psoriasis associated with lower levels of QoL. METHOD Case-control study including 70 subjects with moderate-severe psoriasis and 140 controls without psoriasis. All participants answered the Short Form Health Survey (SF-36), with physical and mental component scores of quality of life, and the Hospital Anxiety and Depression Scale (HADS). Among subjects with psoriasis, the Psoriasis Area and Severity Index (PASI) and the Dermatology Life Quality Index (DLQI) were used, respectively, to measure the severity of psoriasis and the impact of psoriasis on the specific quality of life. RESULTS Compared to controls, patients with psoriasis showed higher HADS depression score and alcohol consumption, and lower QoL. Among subjects with psoriasis, multivariate analysis showed: 1) poorer physical QoL was associated with older age, articular lesions and anxious symptoms, whereas poorer mental QoL was associated with younger age, female sex, genital lesions and depressive symptoms; 2) the higher the severity of psoriasis, the lower the level of QoL and the higher the levels of anxious or depressive symptoms; and 3) female sex and articular or genital location of lesions are linked with higher HADS scores. CONCLUSION Higher scores in anxiety and depression and lower QoL is common in psoriasis, especially among women and those with genital or articular lesions. Dermatologists should give special attention to this subgroup of persons with psoriasis in order to prevent future psychopathology.
Collapse
Affiliation(s)
- José M Martínez-Ortega
- Department of Psychiatry, University of Granada, Granada, Spain; CTS-549 Research Group, Institute of Neurosciences, University of Granada, Granada, Spain
| | - Paloma Nogueras
- Dermatology Service, Virgen de la Nieves University Hospital, Granada, Spain
| | - José E Muñoz-Negro
- Department of Psychiatry, University of Granada, Granada, Spain; UGC Salud Mental, San Cecilio University Hospital and ibs Granada, Spain
| | - Luis Gutiérrez-Rojas
- Department of Psychiatry, University of Granada, Granada, Spain; CTS-549 Research Group, Institute of Neurosciences, University of Granada, Granada, Spain; UGC Salud Mental, San Cecilio University Hospital and ibs Granada, Spain.
| | | | - Manuel Gurpegui
- Department of Psychiatry, University of Granada, Granada, Spain; CTS-549 Research Group, Institute of Neurosciences, University of Granada, Granada, Spain
| |
Collapse
|
3
|
Muñoz-Negro JE, Cuadrado L, Cervilla JA. Current Evidences on Psychopharmacology of Schizoaffective Disorder. Actas Esp Psiquiatr 2019; 47:190-201. [PMID: 31648341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 09/01/2019] [Indexed: 06/10/2023]
Abstract
Schizoaffective disorder (SAD) is a psychotic disorder which has presented a certain nosological controversy. Apart from these difficulties, very few studies focused in SAD as a distinct condition from schizophrenia have been found. This lack of specifical studies on SAD results in a lack of specific evidence about treatment. Currently, its treatment is based mainly on the use of antipsychotics, although there are no specific treatment guidelines for SAD. The objective of this review is to establish which are the most recommended treatments according to evidence available, considering clinical variables such as efficacy, safety, adherence, and tolerance as well as the role of these factors in different subtypes of SAD. This exhaustive review examines experimental and observational studies involving patients with a diagnosis of SAD. It was concluded that more clinical trials performed exclusively on patients affected by SAD are needed. Paliperidone, the only drug with authorized use in SAD, is the one that has the highest quality of studies to support its use. Risperidone, olanzapine, aripiprazole and ziprasidone also have randomized clinical trials supporting their efficacy and safety. In treatment-refractory patients, there are observational studies indicating the usefulness of clozapine. Likewise, there is evidence from observational studies showing the usefulness of lithium and carbamazepine during the treatment maintenance phase. It is necessary to establish the role of combined treatment with mood stabilizers and/or antidepressants.
Collapse
Affiliation(s)
- José E Muñoz-Negro
- UGC de Salud Mental. Hospital Universitario San Cecilio. Servicio Andaluz de Salud. Granada. España ibs Granada
| | - Laura Cuadrado
- Departamento de Psiquiatría. Facultad de Medicina. Universidad de Granada. Granada. España
| | - Jorge A Cervilla
- UGC de Salud Mental. Hospital Universitario San Cecilio. Servicio Andaluz de Salud. Granada. España ibs Granada Departamento de Psiquiatría. Facultad de Medicina. Universidad de Granada. Granada. España
| |
Collapse
|
4
|
Muñoz-Negro JE, Prudent C, Gutiérrez B, Cervilla JA. Paranoia and risk of personality disorder in the general population. Personal Ment Health 2019; 13:107-116. [PMID: 30989831 DOI: 10.1002/pmh.1443] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Revised: 01/14/2019] [Accepted: 03/13/2019] [Indexed: 01/26/2023]
Abstract
BACKGROUND We hypothesized that paranoia is associated with personality disorder (PD) in the general population. METHOD This was a population-based cross-sectional survey carried out in Andalusia (Spain) using a representative sample of 4 507 participants. Paranoia was measured using the Green Paranoid Thought Scale, and risk of having a PD was screened using the Standardized Assessment of Personality Abbreviated Scale whilst borderline personality disorder (BPD) was measured with the CEPER-III Exploratory Interview of Personality disorder. Adjusted Pearsons' correlations between paranoia and PD or BPD were calculated. RESULTS Paranoia was associated with the risk of having PD and, more robustly, with BPD. Both associations held true for both personality outcomes (PD and BPD) when tested for two Green Paranoid Thought Scale paranoia subtypes (persecutory and reference) after accounting for the effects of age, sex and child abuse. CONCLUSIONS Paranoia seems to either augment the risk for, or be part of, PD/BPD. © 2019 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- José E Muñoz-Negro
- Unidad de Salud Mental, Hospital Universitario San Cecilio de Granada, Instituto Biosanitario de Granada, Servicio Andaluz de Salud, Granada, Spain
| | - Cécile Prudent
- Equipe Émergente de Recherche, BePsyLab, Université d' Angers, Angers, France
| | - Blanca Gutiérrez
- Departamento de Psiquiatría, Facultad de Medicina, Universidad de Granada, Granada, Spain
| | - Jorge A Cervilla
- Unidad de Salud Mental, Hospital Universitario San Cecilio de Granada, Instituto Biosanitario de Granada, Servicio Andaluz de Salud, Granada, Spain.,Departamento de Psiquiatría, Facultad de Medicina, Universidad de Granada, Granada, Spain
| |
Collapse
|
5
|
Muñoz-Negro JE, Cervilla JA. The comprehensive treatment of delusional disorder. Rev Psiquiatr Salud Ment 2017; 10:221-223. [PMID: 28476504 DOI: 10.1016/j.rpsm.2017.03.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Revised: 03/13/2017] [Accepted: 03/15/2017] [Indexed: 01/10/2023]
Affiliation(s)
- José E Muñoz-Negro
- UGC de Salud Mental, Complejo Hospitalario Universitario de Granada, Servicio Andaluz de Salud, Granada, España.
| | - Jorge A Cervilla
- UGC de Salud Mental, Complejo Hospitalario Universitario de Granada, Servicio Andaluz de Salud, Granada, España; Departamento de Psiquiatría, Facultad de Medicina, Universidad de Granada, Granada, España
| |
Collapse
|
6
|
Muñoz-Negro JE, Ibanez-Casas I, de Portugal E, Ochoa S, Dolz M, Haro JM, Ruiz-Veguilla M, de Dios Luna Del Castillo J, Cervilla JA. A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder. Schizophr Res 2015; 169:248-254. [PMID: 26585220 DOI: 10.1016/j.schres.2015.10.039] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Revised: 10/23/2015] [Accepted: 10/26/2015] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Since the early description of paranoia, the nosology of delusional disorder has always been controversial. The old idea of unitary psychosis has now gained some renewed value from the dimensional continuum model of psychotic symptoms. AIMS 1. To study the psychopathological dimensions of the psychosis spectrum; 2. to explore the association between psychotic dimensions and categorical diagnoses; 3. to compare the different psychotic disorders from a psychopathological and functional point of view. MATERIAL AND METHODS This is an observational study utilizing a sample of some 550 patients with a psychotic disorder. 373 participants had a diagnosis of schizophrenia, 137 had delusional disorder and 40 with a diagnosis of schizoaffective disorder. The PANSS was used to elicit psychopathology and global functioning was ascertained using the GAF measure. Both exploratory and confirmatory factor analyses of the PANSS items were performed to extract psychopathological dimensions. Associations between diagnostic categories and dimensions were subsequently studied using ANOVA tests. RESULTS 5 dimensions - manic, negative symptoms, depression, positive symptoms and cognitive - emerged. The model explained 57.27% of the total variance. The dimensional model was useful to explained differences and similarities between all three psychosis spectrum categories. The potential clinical usefulness of this dimensional model within and between clinical psychosis spectrum categories is discussed.
Collapse
Affiliation(s)
- José E Muñoz-Negro
- Mental Health Unit, Granada University Hospital, Granada, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Department of Psychiatry, University of Granada, Spain
| | - Inmaculada Ibanez-Casas
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Department of Psychiatry, University of Granada, Spain
| | - Enrique de Portugal
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Gregorio Marañón Hospital, Madrid, Spain
| | - Susana Ochoa
- Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Sant Boi de Llobregat, Barcelona, Spain
| | - Montserrat Dolz
- Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Sant Boi de Llobregat, Barcelona, Spain
| | - Josep M Haro
- Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Sant Boi de Llobregat, Barcelona, Spain
| | | | | | - Jorge A Cervilla
- Mental Health Unit, Granada University Hospital, Granada, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Department of Psychiatry, University of Granada, Spain.
| |
Collapse
|
7
|
Buendía-Eisman A, Feriche-Fernández E, Muñoz-Negro JE, Cabrera-León A, Serrano-Ortega S. [Evaluation of a school intervention program to modify sun exposure behaviour]. Actas Dermosifiliogr 2007; 98:332-44. [PMID: 17555676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023] Open
Abstract
INTRODUCTION Nonmelanoma skin cancer is the most prevalent and incident tumor in the world, being sun exposure the most important risk factor. Childhood and adolescence are the periods where sun exposure is greatest. An intervention to modify sun-related behaviours is essential for skin cancer prophylaxis. MATERIAL AND METHODS We carried out a quasi-experimental study on a school population of Granada with ages ranging from 11-12 years. The control and study groups completed a questionnaire prior to the intervention with educational program and thereafter. We performed a random conglomerate sampling of 628 teenagers. Statistical analysis was carried out using the Mc Nemar and Wilcoxon tests. RESULTS After the intervention, the study group showed marked improvement in the results concerning knowledge about sun exposure and skin (OR = 2.89), sun exposure and environment (OR = 2.23), and sun exposure and health (OR = 1.4) as well as in attitudes and healthy behaviour regarding sun exposure (OR = 4.2). This difference was statistically significant compared to the control group. CONCLUSIONS 1. Before planning a campaign for primary prophylaxis of skin cancer it is necessary to know the information and knowledge of the target population. 2. The risk of acute, intermittent sun exposure and the use of different means of photoprotection should be stressed. 3. In our study group the rate of sun burn has decreased.
Collapse
Affiliation(s)
- A Buendía-Eisman
- Area de Dermatología, Facultad de Medicina, Universidad de Granada, Granada.
| | | | | | | | | |
Collapse
|